Showing results (81-90 of 156) with videos related to
Sort By:
Pageof 16
Diabetes|September 1, 2012
Human β-cell killing by autoreactive preproinsulin-specific CD8 T cells is predominantly granule-mediated with the potency dependent upon T-cell receptor avidityRobin R Knight, Deborah Kronenberg, Min Zhao, et al.Haematologica|December 18, 2012
Differential effects of rapamycin and retinoic acid on expansion, stability and suppressive qualities of human CD4(+)CD25(+)FOXP3(+) T regulatory cell subpopulationsCristiano Scottà, Marianna Esposito, Henrieta Fazekasova, et al.Frontiers in Immunology|July 15, 2021
Mapping T Cell Responses to Native and Neo-Islet Antigen Epitopes in at Risk and Type 1 Diabetes SubjectsSefina Arif, Irma Pujol-Autonell, Yogesh Kamra, et al.Diabetologia|October 8, 2020
Type 1 diabetes can present before the age of 6 months and is characterised by autoimmunity and rapid loss of beta cellsMatthew B Johnson, Kashyap A Patel, Elisa De Franco, et al.Nature Communications|November 28, 2022
Low-dose IL-2 reduces IL-21<sup>+</sup> T cell frequency and induces anti-inflammatory gene expression in type 1 diabetesJia-Yuan Zhang, Fiona Hamey, Dominik Trzupek, et al.Journal of Immunological Methods|January 31, 2016
T-cell libraries allow simple parallel generation of multiple peptide-specific human T-cell clonesSarah M Theaker, Cristina Rius, Alexander Greenshields-Watson, et al.Diabetes|August 14, 2009
Validity and reproducibility of measurement of islet autoreactivity by T-cell assays in subjects with early type 1 diabetesKevan C Herold, Barbara Brooks-Worrell, Jerry Palmer, et al.Journal of Clinical Immunology|November 25, 2025
CXCL13 as a Biomarker of Complex Common Variable ImmunodeficiencyIoasaf Karafotias, Helene Martini, Charlotte V Lee, et al.Frontiers in Immunology|April 25, 2020
Multiplex T Cell Stimulation Assay Utilizing a T Cell Activation Reporter-Based Detection SystemSarah E Mann, Zhicheng Zhou, Laurie G Landry, et al.Diabetologia|October 23, 2015
Innate and adaptive immunity to human beta cell lines: implications for beta cell therapyCornelis R van der Torren, Arnaud Zaldumbide, Dave L Roelen, et al.Pageof 16